Michelle Tutt currently serves as the Head of Early Development Asset Operations at Ipsen since May 2024, after holding various roles including Director of Project Management and Senior Global Project Manager. Prior to Ipsen, Michelle was with Reneo Pharmaceuticals from September 2018 to May 2024, where responsibilities included leading project management and facilitating multidisciplinary teams to ensure alignment with company strategies during the development of clinical trials. Michelle's career began at Pfizer, where a progression through roles including Senior Principal Scientist and Team Coordinator involved managing large project portfolios in drug discovery and leading research teams across different therapeutic areas. Michelle holds a BSc in Physiology from the University of St Andrews.
This person is not in any teams
This person is not in any offices